1 / 9

Global Subsidy for ACT and Diagnostics

Explore the importance of including diagnostics in the global subsidy debate for wide access to ACT, highlighting key issues at the country level and innovative solutions such as bundling ACT with RDTs and ensuring quality and affordability of diagnostics. Discover strategies like HOMAPAK in Uganda and tools for evaluating RDT quality. Address affordability challenges for RDTs and propose solutions to bridge gaps and reduce costs through partnerships and market strategies.

holmesmichele
Download Presentation

Global Subsidy for ACT and Diagnostics

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Wednesday July 18, 2007APPMG Meeting ACT Global Subsidy: Perspective from Diagnostics Vinand M Nantulya FIND Foundation for Innovative New Diagnostics

  2. ACT Global Subsidy Wide access to ACT is of interest and we fully endorse that. But diagnostics needs to be included in this debate. It is important to link malaria diagnosis tothesubsidized ACT to avoid misuse and wastage of ACT. Misuse of current drugs is a major problem in both public and private sector and change may be more difficult in the informal sector.

  3. Key issues at Country Level Bundling ACT with RDTs Ensuring quality of RDTs. Ensuring affordability of proper diagnosis and treatment.

  4. Issue: Bundling ACT and RDTs Examine Uganda’s practical approach known as HOMAPAK. Originally designed to use Chloroquine/SP for home-based management of malaria fever in children using community health workers. ACT can be introduced into the kit together with RDTs.

  5. Issue: Ensuring Quality of RDTs FIND is examining the possibility of tools to evaluate quality of RDTs, through the use of positive wells. These would empower governments to evaluate RDTs close to the point of actual use in the field. These tools could be available in 6 months.

  6. Issue: Affordability of current RDTs For current RDTs, there is adequate competition in the market place. Local production could further bring down the price. For new RDTs that FIND is developing, the strategy is different as these will start as single or limited source.

  7. Issue: Affordability of single source RDT

  8. But the cost of diagnostics has two vital components Cost to Serve (up to 20% of cost of dx) Cost of Goods • Training • Quality assurance • Maintenance • Provide solutions to bridge gaps and reduce costs + • Hardware • Laboratory strengthening (infrastructure) • Partners • Governments • Bilateral organizations • NGOs/Donors • Link price to volume (using GAMMSMor Global Accelerated Market Maturation) Software Quality Standardization Accountability ?Laboratory accreditation

More Related